Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02490267
Other study ID # DALA1020
Secondary ID
Status Completed
Phase N/A
First received June 25, 2015
Last updated March 15, 2016
Start date June 2014
Est. completion date July 2015

Study information

Verified date March 2016
Source Moorfields Eye Hospital NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority Research Ethics Committee:
Study type Observational

Clinical Trial Summary

The management of childhood glaucoma (CG), childhood cataract (CC) and other birth defects affecting the eyes requires frequent hospital attendances and often multiple surgical and medical interventions, and are often associated with poor vision. Chronic medical conditions and vision impairment can affect quality of life (QoL). The QoL of children with the above conditions has not previously been evaluated.


Description:

We wish to evaluate health related and vision related quality of life (HRQoL, VRQoL) in children age 2 to 16 years with childhood glaucoma (CG), childhood cataract (CC) and congenital eye defects microphthalmia, anophthalmia or coloboma (MAC).

We will recruit children who attend the children's eye clinics at Moorfields Eye Hospital at City Road. We will include the following subgroups:

A) children with primary or secondary glaucoma B) children with cataract or previously treated for cataract C) children with microphthalmia, anophthalmia or coloboma D) control group: agematched children without eye and vision problems. We will ask children and their carers to complete two age appropriate, validated questionnaires, the PedsQL (health related quality of life) and the Cardiff Visual Ability Questionnaire for Children. From the medical notes, we will record diagnosis and best corrected visual acuity with both eyes open. We will also record details of previous and current treatment, such as number of previous surgical interventions (sum of interventions right and left eye) and number of current topical medications (sum of eyedrop applications per day right and left eye).


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 2 Years to 16 Years
Eligibility Inclusion Criteria:

A) children with primary or secondary glaucoma B) children with cataract or previously treated for cataract C) children with microphthalmia, anophthalmia or coloboma D) control group: age-matched children without eye and vision problems

Exclusion Criteria:

- Ocular hypertension not requiring treatment; visually not significant cataract; inability to communicate in English; surgical intervention (incisional) within one month of potential date of completing questionnaire (before or after)

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Intervention

Other:
Quality of Life questionnaire


Locations

Country Name City State
United Kingdom Moorfields Eye Hospital NHS Foundation Trust London

Sponsors (1)

Lead Sponsor Collaborator
Moorfields Eye Hospital NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of babies requiring treatment for retinopathy of prematurity in the UK. Captured in questionnaire 1 year No
Secondary Demographic characteristics of babies that need treatment, Captured in questionnaire 1 year No
Secondary Outcome of the treatment at 1 year follow up: anatomical and functional Captured in questionnaire 1 year No
Secondary Type of treatment administered Captured in questionnaire 1 year No